MUSGROVE LEUKAEMIC GROUP SOMERSET
Projects funded by the M.L.G.S are ensuring patients attending Musgrove Park Hospital, Taunton receive treatment for leukaemia and related blood disorders by the most up-to-date techniques whilst research is helping to combat these dreaded diseases on a worldwide basis.
Financial health, per its FY2026 accounts
The accounts state that the charity is in a sound financial position with unrestricted reserves of £887,453, which exceeds its stated policy target of approximately £200,000. The charity reported total incoming resources of £47,746 and total expenditure of £30,975 for the year, resulting in a net surplus. The trustees confirmed that overheads are minimal, currently under 1% of funds raised.
What the accounts disclose
“The Group attempts to maintain reserves of approximately £200,000” — page 7
Structured financials (annual return, FY ending 28/02/2022)
Trustees
- TRISH REEDchair
- BERNARD ALLEN REED
- DAVID JOHN EDWARDS
- MARGARET SMITH
- MAUREEN HUDSON
- MS JANE ALLIN
- PAT CORNISH
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 28/02/2026 | £48k | £31k |
| 28/02/2025 | £55k | £95k |
| 29/02/2024 | £48k | £26k |
| 28/02/2023 | £54k | £2k |
| 28/02/2022 | £535k | £962 |
Common questions
Is MUSGROVE LEUKAEMIC GROUP SOMERSET financially healthy?
Per its FY2026 accounts: The accounts state that the charity is in a sound financial position with unrestricted reserves of £887,453, which exceeds its stated policy target of approximately £200,000. The charity reported total incoming resources of £47,746 and total expenditure of £30,975 for the year, resulting in a net surplus. The trustees confirmed that overheads are minimal, currently under 1% of funds raised. Its FY2026 accounts were independently examined.